News | July 28, 2023
Biocon Foundation releases 2nd edition of consensus guidelines for head & neck cancer
Marks the World Head & Neck Cancer Day at the OCTF Conference
Marks the World Head & Neck Cancer Day at the OCTF Conference
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
For the treatment of Superficial Femoral Artery
These initiatives aim to improve access to healthcare for rare disease patients
Farxiga is expected to have such a strong influence on the market due to the impressive results
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Subscribe To Our Newsletter & Stay Updated
